Insmed | INSM - Loan Capital


Insmed reported $540.96M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
BioMarin Pharmaceutical USD 597.18M 513K Dec/2025
Cytokinetics USD 1.12B 957.23M Dec/2025
DBV Technologies USD 0 0 Mar/2025
Gilead Sciences USD 22.14B 5M Sep/2025
Heron Therapeutics USD 149.65M 157K Sep/2024
Insmed USD 540.96M 1.24M Dec/2025
Novartis USD 24.24B 174M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Sarepta Therapeutics USD 828.97M 206.17M Dec/2025
Ultragenyx Pharmaceutical USD 763.74M 19.02M Sep/2025
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025